Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
1.580
-0.110 (-6.51%)
At close: Sep 26, 2025, 4:00 PM EDT
1.610
+0.030 (1.90%)
After-hours: Sep 26, 2025, 7:38 PM EDT
CNTB Revenue
Connect Biopharma Holdings had revenue of $48.00K in the quarter ending June 30, 2025, a decrease of -99.80%. This brings the company's revenue in the last twelve months to $1.97M, down -91.85% year-over-year. In the year 2024, Connect Biopharma Holdings had annual revenue of $26.03M.
Revenue (ttm)
$1.97M
Revenue Growth
-91.85%
P/S Ratio
44.51
Revenue / Employee
$31,694
Employees
62
Market Cap
88.04M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CNTB News
- 23 days ago - Connect Biopharma Announces Two Presentations at the European Respiratory Society (ERS) Congress 2025 - GlobeNewsWire
- 24 days ago - Connect Biopharma Completes Termination of its American Depositary Receipt Program and Directly Lists its Ordinary Shares on Nasdaq - GlobeNewsWire
- 4 weeks ago - Connect Biopharma to Present at Two Upcoming Investor Conferences in September - GlobeNewsWire
- 6 weeks ago - Connect Biopharma Teams with Ickey Woods and the Jovante Woods Foundation to Expand Asthma Education Program Nationwide - GlobeNewsWire
- 6 weeks ago - Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors - GlobeNewsWire
- 2 months ago - Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq - GlobeNewsWire
- 2 months ago - Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewsWire